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Abstract 
Background: The use and demand of echocardiography has increased worldwide. 
In developed countries, this has not been translated into improved access outside 
tertiary centres. Previous studies have favoured the appropriate use of 
echocardiography over its clinical impact, limiting generalisability to resource-
constrained settings. 
Objectives: To assess the impact of an echocardiographic service at district hospital 
level in Cape Town, South Africa. 
Methods: A prospective, cross-sectional study was performed. A total of 210 
consecutive patients, referred to the echocardiography clinic over a five-month 
period, were recruited. Transthoracic echocardiography was evaluated by its 
indication, new information provided, correlation with referring doctor’s diagnosis 
and subsequent management plan. Impact included the escalation and de-escalation 
in treatment, as well as usefulness without a change in management. 
Results: The results show that 84% of the patients’	management was impacted by 
echocardiography. Valvular lesions were the main indication. The most frequent 
contribution was information provided towards the diagnosis of heart failure and 
assessment post-myocardial infarction. Fifty-six per cent of the echocardiograms 
confirming the referring doctor’s diagnosis still had a significant impact. The 
rational prescription of medication had the major impetus, followed by de-
escalation of therapy and screening patients for referral to tertiary facilities.  
Conclusion: Echocardiography has a positive impact on patient management 
outside tertiary settings, where the definition of impact appears to be different. The 
value of a normal study, screening prior to upstream referral and usefulness 
irrespective of change has been established. This should alert policy makers towards 
the risk of restricted access and promote training.	
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Introduction  
The use of and demand for echocardiography have shown a marked increase 
worldwide.[1] As special investigation it provides accurate haemodynamic as well as 
anatomic information non-invasively at the bedside.[1-3] 
 
Developing countries are showing a steady rise in non-communicable diseases, with 
cardiovascular diseases proving the largest burden in South Africa.[4,5] The dual 
burden of communicable and non-communicable diseases is disproportionally 
affecting vulnerable lower-income groups in urban settings.[4] Ironically, patients 
accessing hospitals with the least available specialist expertise were shown to have 
the highest number of co-morbidities.[6] Access to special investigations such as 
echocardiography, a skill still held mainly by specialist cardiologists, remains 
restricted and uneven in South Africa.  
 
Recent advances in the developed world include open access echocardiography 
(OAE), which is requested and the results thereof acted on by general practitioners, 
hand-held devices as well as point-of-care studies by non-cardiologists.[2,7-9] Other 
than screening patients, appropriate care can be implemented at an earlier stage and 
waiting times for or referrals to tertiary care can be reduced. The main limitation for 
the roll-out of echocardiography to primary care is the lack of training.[10] 
 
A few recent studies have reviewed the utility of echocardiography in large, mainly 
tertiary centres in the developed world.[11-13] The use of echocardiography is mainly 
driven by appropriate use criteria (AUC) in these settings. These AUC identify 
common clinical scenarios where echocardiography can be applied and aim at 
improving health outcomes by means of the equitable allocation of resources in 
cardiovascular imaging.[14] There is a paucity of data regarding the impact of 
echocardiography in sub-Saharan Africa. Various definitions of impact and the 
different concepts of a district or general hospital limit the generalisability to 
resource-constrained areas, where the clinical impact of echocardiography may be of 
more value than the broadly accepted clinical indications. 
 
Therefore, our objective was to assess the clinical impact of an echocardiographic 
service in a district hospital in South Africa. Further conclusions on the demand to 
access and need for training in echocardiography were drawn.  
 
 
Methods 
A prospective, descriptive, cross-sectional study was conducted at Victoria Hospital, a 
district-level hospital in Cape Town serving a patient population of nearly 600 000 
(2014), consisting mainly of low and middle socio-economic groups. The study 
cohort consisted of patients referred to the once-weekly echocardiography service, 
during a 14-week period between September 2013 and January 2014. 
 
Recruitment of study participants was held on the day of the pre-booked echo 
appointments. All in- and outpatient referrals were considered, regardless of age and 
comorbidities. Patients unable to give written consent were excluded. Only screening 
transthoracic echocardiography (TTE) was included and performed by a registered 
cardiologist, accredited to perform echocardiography.  
 3	
 
EpiCalc (freeware, Version 1.02, 2000) was used to calculate the sample size. It was 
assumed that 80% of management would change due to results of the 
echocardiogram. As the study describes a single proportion, to achieve a confidence 
level of 95%, with a precision of 5% (thus a margin of error of 10%), a sample size of 
245 patients was required. 
 
Data were collected prospectively, meaning as the echo was performed. One 
questionnaire was completed by the participant, with the help of a research assistant, 
and pertained to patient characteristics and medical history. The cardiologist who 
performed the echocardiogram completed a second questionnaire in order to establish 
its impact by assessing the indication, new information obtained from the 
echocardiogram, correlation with the referring doctor’s diagnosis and the 
management plan thereafter. AUC were used to classify indications explicitly. The 
average waiting period was randomly calculated on four dates, reviewing the time 
until the next available appointment. 
 
The cardiologist conducted the echocardiograms using a Toshiba Nemio machine, 
using an adult echocardiography probe PST-25AT (1.8–4.2 mHz). The patients were 
screened in the supine and left lateral positions. Examinations were viewed in real 
time and done in standard transthoracic views, parasternal long and short axis with 
apical four-chamber views; subxyphoid views were included when indicated. M-
mode, 2D and colour flow Doppler were utilised. Ejection fraction was measured 
using the Teicholz method.[15] Regional wall motion was visually evaluated in the 
above-mentioned views. Continuous Doppler was not available on the machine, but 
colour flow Doppler was used when necessary. M-mode recording was done and 
printed out when deemed necessary, but not stored. The echocardiograms performed 
were for screening purposes only and were not standard transthoracic evaluations. 
Even though some patients had repeated TTE, most patients did not have a baseline 
standard study. 
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Impact was classified according to adapted criteria (Table 1).11-13 
 
Table 1: Clinical impact criteria 
Impact 
level	  Description	
Active	 Escalation	 More rational drug therapy 
Confirmation of vegetation 
Cardioversion required 
Referred for further imaging (angiography 
or nuclear medicine study) 
Referred to tertiary cardiology services 
Other referrals: palliative care programme, 
disability grant assessment	
 De-escalation	 Reassurance of normal study, omitting 
further testing or avoiding further referral	
 No change, but 
clinically useful	 Contesting clinical suspicion / diagnostic value 
Repeat echo advised / monitoring purpose 
Cleared for theatre	
No 
impact	  Continue current management plan Confirming clinical suspicion with no 
change in management	
Total impact = Escalation + De-escalation + No change, but clinically useful 
 
 
Data were captured with Excel v14.0.0 (Microsoft, 2011) and analysis was performed 
on Stata 12.0 (Statacorp, Texas, 2011). Where data were not normally distributed (e.g. 
age), a Kruskal-Wallis test was used. Pearson chi-square tests or Fisher exact (if the 
expected frequency of a group was smaller than 5) were used to calculate the 
statistical significance of the different proportions. Statistical significance was 
accepted as a p-value of less than 0.05. Prevalence ratios were then calculated. Absent 
data were perceived as missing completely at random, as categorical data were 
collected as tick sheets. 
 
This study was approved by the Health Science Research Ethics Committee of the 
University of Cape Town (HREC 382/2013). Each participant voluntarily agreed to 
participation in the study by means of written consent. A study number was allocated 
to each participant in the data sets in order to ensure confidentiality. 
 
 
 
 
 
 
 5	
Results 
A total of 210 participants were recruited (see Figure 1). Approximately one-third of 
the patients did not attend their appointment date. Patient characteristics, 
comorbidities and referral patterns, all in relation to the overall impact level each 
group was associated with, are tabulated in Table 2. The majority of the participants 
were referred by the Medical Department, either from the ward or via the Outpatient 
Department.  
 
Figure 1: Recruitment of participants 
 
Self-reported and documented comorbidities noted nine (4.29%) HIV-positive 
participants, five cases (2.82%) of rheumatic heart disease and four (2.26%) 
participants with a previous mitral valve replacement, all associated with impact. It 
was not documented whether these valve replacements were initially indicated for 
rheumatic heart disease. 
 
Of the participants, 131 (62.38 %) had a smoking history, one-third of these 
indicating a current smoking habit. Of those older than 16, 34 (17.44%) indicated that 
they were employed, while 29 (13.81%) received disability grants and 63 (30%) were 
pensioners. 
 
An average number of 17 echocardiograms were performed per clinic during the 
study period. The average waiting time, until the next available appointment, was 89 
days. 
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Table 2: Patient characteristics referred for TTE 
 Total impact	 No impact	 Total	
Age (mean, minimum, maximum)	 52 (2, 86)	 60 (25; 87)	 50 (SD 20,13)	
Male	 90 	 51.14%	 18 	 52.94%	 108 	 51.43%	
Female	 87 	 49.43%	 15 	 44.12%	 102 	 48.57%	
Employed (> 16 years old)	 27 	 15.34%	 7 	 20.59%	 34 	 17.44%	
Pensioners	 49 	 27.84%	 14 	 41.18%	 63 	 30.00%	
Receiving DG	 24 	 13.64%	 5 	 14.71%	 29 	 13.81%	
Currently inpatient	 48 	 27.27%	 5 	 14.71%	 53 	 25.24%	
Referring facility	  	   	   	  
Medical ward	 76 	 43.18%	 16 	 47.06%	 92 	 43.81%	
ED	 34 	 19.32%	 7 	 20.59%	 41 	 19.52%	
MOPD	 32 	 18.18%	 9 	 26.47%	 41 	 19.52%	
POPD	 12 	 6.82%	 0 	 0	 12 	 5.71%	
CHC	 12 	 6.82%	 0 	 0	 12 	 5.71%	
DH	 5 	 2.84%	 0 	 0	 5 	 2.38%	
Private sector	 1 	 0.57%	 0 	 0	 1 	 0.48%	
Other	 4 	 2.27%	 1 	 2.94%	 5 	 2.38%	
Unknown source of referral	 1 	 0.57%	 0 	 0	 1 	 0.95%	
Comorbidities	       
Hypertension	 91 	 51.70%	 28 	 82.35%	 119 	 56.57%	
Ischaemic heart disease	 54 	 30.68%	 13 	 38.24%	 67 	 31.9%	
Hypercholesterolaemia	 49 	 27.84%	 12 	 35.29%	 61 	 29.05%	
Diabetes mellitus	 40 	 22.72%	 9 	 26.47%	 49 	 23.33%	
Cardiac failure 	 30 	 17.05%	 6 	 17.65%	 36 	 17.14%	
Atrial fibrillation 	 16 	 9.09%	 2 	 5.88%	 18 	 8.57%	
COPD	 15 	 8.52%	 2 	 5.88%	 17 	 8.1%	
Known cardiomyopathy 	 13 	 7.39%	 3 	 8.82%	 16 	 7.62%	
Stroke 	 12 	 6.82%	 1 	 2.94%	 13 	 6.19%	
HIV	 9 	 5.11%	 0 	 0	 9 	 4.29%	
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Thyroid disease	 8 	 4.55%	 0 	 0	 8 	 3.81%	
Obesity	 4 	 2.27%	 2 	 5.88%	 6 	 2.86%	
Rheumatic heart disease 	 5 	 2.84%	 0 	 0	 5 	 2.38%	
Mitral valve replacement 	 4 	 2.27%	 0 	 0	 4 	 1.9%	
Habits	       
Ex-smoker	 70 	 39.77%	 15 	 44.12%	 85 	 40.48%	
Current smoker	 38 	 21.59%	 8 	 23.52%	 46 	 21.9%	
Alcohol	 30 	 17.04%	 9 	 26.47%	 39 	 18.57%	
Drugs (ex or current)	 16 	 9.09%	 1 	 2.94%	 17 	 8.1%	
TOTAL (n =)	 176	 83.81%	 34	 16.19%	 210	 100%	
ED: Emergency Department; MOPD: Medical Outpatients Department; POPD: Paediatric Outpatients 
Department; CHC: Community Health Care Centre; DH: (Neighbouring) District Hospital; COPD: 
Chronic Obstructive Pulmonary Disease 
Two main groups “Total impact” and “No impact” each has subset per criterion, tabled by number and 
percentage, e.g., Ex-smokers: 70 (39.77%) associated with “Total impact” and 15 (44.12%) associated 
with “No impact”.  Percentage in brackets calculated per main group, e.g. 15 participants of all those 
with “no impact” (i.e. out of 34 participants) were non-smokers. 
 
 
 
Clinical use and association with impact 
Our study found that 84% of TTEs had an impact on patients’ management. In total, 
51% resulted in an escalation and 19% in de-escalation of management, while 14% 
had an impact without a change in management.  
 
Valvular lesions were the main indication for referral (Table 3). Only one patient’s 
indication was seen as inappropriate when compared to AUC.14 
 
Table 3: Indications and their association with clinical impact 
 Total impact 	 No impact	 Total 	 Prevalence 
ratio 
(95% CI)	
Evaluation of valvular 
function	 66 	 37.5%	 7 	 20.59%	 73 	 34.76%	 1.01–1.26	
Unknown cause of 
heart failure	 47 	 26.7%	 7 	 20.59%	 54 	 25.71%	 0.93–1.19	
Post-myocardial 
infarction (for regional 
wall motion 
abnormalities)	
26 	 14.77%	 9 	 26.47%	 35 	 16.67%	 0.61–0.90	
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Suspected hypertensive 
heart disease	 18 	 10.23%	 16 	 47.06%	 34 	 16.19%	 0.38–0.72	
Rhythm abnormality on 
ECG	 31 	 17.61%	 1 	 2.94%	 32 	 15.24%	 1.08–1.31	
Cardiomegaly, found 
clinically and 
radiologically, not 
known with CCF	
22 	 12.5%	 2 	 5.88%	 24 	 11.43%	 0.97–1.27	
Known 
cardiomyopathy	 13 	 7.39%	 3 	 8.82%	 16 	 7.62%	 0.79–0.89	
Evaluation of chest 
pain of unknown cause	 14 	 7.95%	 2 	 5.88%	 16 	 7.62%	 0.86–1.27	
History suggestive of 
arrhythmia, e.g. 
palpitation, light-
headedness, pre-
syncope or syncope	
14 	 7.95%	 0 	 0	 14 	 6.67%	 0.78–0.88	
Evaluation of 
cardiovascular source 
of embolus	 9 	 5.11%	 1 	 2.94%	 10 	 4.76%	 0.87–1.34	
Other	 21 	 11.93%	 1 	 2.94%	 22 	 10.48%	 -	
TOTAL (n =)	 176	 83.81%	 34	 16.19%	 210	 100%	  
 
Other: Pulmonary hypertension, suspected infective endocarditis, new cardiomyopathy, evaluation of 
aortic disease, suspected pulmonary embolism 
ECG: Echocardiogram; CCF: Congestive cardiac failure 
Note: One participant may have more than one indication for TTE. 
 
The major contribution of TTE was the information provided in the diagnosis of heart 
failure (29.0%) and ischaemic heart disease (23.8%) (Table 4). Of all participants, 
one-third have impaired left ventricular (LV) function. Three cases of apical thrombi 
were identified post-myocardial infarction, which resulted in the initiation of 
anticoagulation therapy. 
 
The most common valve lesions identified, in order of prevalence, are tabulated 
separately (Table 4). Of these, mitral stenosis, discerning aortic scleroses from 
stenosis, identifying non-pathological murmurs and aortic regurgitations were 
statistically significantly associated with clinical impact. In addition to the five known 
prior to the TTE, three more participants were diagnosed with rheumatic heart 
disease; the total prevalence being 3.8% in our study cohort. 
 
Six participants were diagnosed with cor pulmonale and four with pulmonary 
hypertension, none of them known to be suffering from COPD.  
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Table 4: New information found on TTE 
 Total impact 
(n = 176)	 No impact (n = 34)	 Total (n = 210)	 Prevalence ratio (95% 
CI)	
Detection of LV 
systolic 
dysfunction	 57 	 32.39%	 9 	 26.47%	 66 	 31.43%	 0.93–1.18	
Cause of heart 
failure 
established	 28 	 15.91%	 6 	 17.65%	 34 	 16.19%	 0.82–1.16	
Cause of heart 
failure confirmed	 24 	 13.64%	 3 	 8.82%	 27 	 12.86%	 0.92–1.24	
Total: heart failure  61 29.05%  
Wall motion 
abnormality 
found	 28 	 15.91%	 4 	 11.76%	 32 	 15.24%	 0.91–1.22	
Wall motion 
abnormality ruled 
out	 12 	 6.82%	 6 	 17.65%	 18 	 8.57%	 0.48–0.92	
Total: wall motion 
abnormalities 
 50 23.81%  
Left ventricular 
hypertrophy 
(LVH)	 29 	 16.48%	 14 	 41.18%	 43 	 20.48%	 0.54–0.82	
Congenital heart 
disease	 4 	 2.27%	 0 	 0	 4 	 1.9%	 0.79–0.89	
LV aneurysm	 1 	 0.57%	 0 	 0	 1 	 0.48%	 0.78–0.89	
Valvular lesions	
Mitral 
regurgitation	 56 	 26.67%	 5 	 15.15%	 61 	 29.05%	 1.01–1.25	
Tricuspid 
regurgitation	 34 	 16.19%	 5 	 15.15%	 39 	 18.57%	 0.90–1.19	
Aortic sclerosis 
discerned from 
aortic stenosis	 21 	 11.93%	 9 	 26.47%	 30 	 14.29%	 0.55–0.88	
Aortic stenosis	 17 	 8.10%	 3 	 9.09%	 20 	 9.52%	 0.83–1.23	
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Functional 
murmur	 15 	 8.52%	 0 	 0	 15 	 7.14%	 0.77–0.88	
Mitral stenosis	 14 	 6.67%	 0 	 0	 14 	 6.67%	 0.78–0.88	
Aortic 
regurgitation	 8 	 3.81%	 0 	 0	 8 	 3.81%	 0.79–0.89	
Total (n =)	 176	 83.81%	 34	 16.19%	 210	 100%	  
 
Despite the fact that 56% (118 participants) of all TTEs confirmed the referring 
doctor’s diagnosis, these were still statistically significantly linked to impact (CI 
0.64–0.80) (Figure 2). Of all TTEs, 39% (82 participants) contested the pre-referral 
diagnosis. In total, 88% (30 participants) of TTEs who did not have an impact were 
associated with an accurate correlation with pre-referral assessment. 
 
 
Figure 2: Correlation of referring doctor’s diagnosis with impact of echo. 
  
 
Spectrum of clinical impact 
TTE was found to be most useful in the rational prescription of medication (80 
participants). Twenty-seven participants, one-fifth of those who had an escalation in 
management, required referral to tertiary services (Figure 3). Of these upstream 
referrals, nine patients were referred for surgery: five were for valve replacements, 
three for the correction of atrial septal defects and one for surgery of a myxoma. 
Three patients required referral to the hospital’s social worker for a disability grant 
due to the severity of their disease. 
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Figure 3: Upstream referrals after echo. 
CMO: Cardiomyopathy; ECG: Electrocardiogram 
Legends: Impact or upstream referral clinic; number of cases; percentage of escalated management 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
De-escalation of care, back to the primary health care services, was recommended in 
40 cases. Fifteen participants were offered reassurance for non-pathological murmurs 
and six participants for idiopathic chest pain, preventing further testing or referral to a 
higher level of care. The remaining half of this group benefited by TTE ruling out 
cardiac sources of emboli, structural causes for perceived arrhythmia (symptomatic or 
on electrocardiogram), pulmonary hypertension and infective endocarditis. 
 
Echocardiograms performed on 29 participants resulted in no change in management, 
but provided clinically useful information. Of these, two-thirds (16 participants) were 
advised to have follow-up echocardiograms (implying monitoring of current 
condition), 11 participants had contested the referring doctor’s diagnosis prior to the 
echocardiogram and two were cleared for surgery. 
 
Behavioural advice, for example direct advice on alcohol consumption, weight 
reduction and smoking cessation, was documented, but not analysed. Three female 
patients were advised against future pregnancies due to postpartum cardiomyopathy. 
 
 
Discussion 
Our study found that the vast majority (83.8%) of echocardiograms had a positive 
impact on patients referred to a district hospital	 – a proportion even higher than 
reported in settings of developed countries (32–76%).[12,13] The diversity of patients’	
ages, comorbidities and sources of referral indicated the broad practice and value of 
this mode of investigation.  
 
The value of a prospective study is that single echocardiographic assessment in a non-
tertiary setting can immediately address a focused, clinical question or suspicion 
raised, which may immediately indicate the impact or the lack thereof. This definition 
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of impact appears to be different from previous larger impact studies, which were 
done either in tertiary settings or in community hospitals that had cardiology services 
available.[12,13] A few older studies done at district hospitals either reviewed the 
impact more than 30 years ago, using only M-mode, or focused on the intensive care 
units.[3,16,17] The lack of generalisability to current district hospital practice seems 
obvious, especially in resource-constrained settings.  
 
We have established the role of de-escalation in therapy and continuation of 
management. This potential decrease in referral to tertiary specialists seems similar to 
other studies.[7,9,18] Previous studies have cautioned about undervaluing a normal 
study.[8,11,19,20] This benefit has been proven by our study by TTE having impact in 
32.9% (n = 69) of all the participants referred, without escalating management. Its use 
in screening pre-screened patients is evident, with a particularly high impact level in 
all paediatric patients, mainly aiding in de-escalation of services after a murmur had 
been auscultated prior to referral. This has been undervalued by previous studies.[12,16] 
Our study has shown that impact does not necessarily translate into a change in 
management. Many patients require follow-up; this is seen as valid indications in 
itself in early and late stages of disease, without even having a change in clinical 
status.[14] 
 
The major change in management appeared to be the rational prescription of 
medicine. The other main benefit was determining which patients require up-referral 
to tertiary services, for example those requiring surgery. 
 
South Africa does not use AUC. However, the fact that 99% of indications could be 
classified accordingly indicates the high appropriate use in our district hospital. The 
most common indication in our case was suspected valve disease. Its significance 
could not be statistically linked to impact, perhaps owing to the small sample size 
achieved. New information gathered was nonetheless significant for mitral stenosis 
and aortic regurgitation; this echoes the finding of a previous audit of the beneficial 
value of assessing diastolic (more than systolic) murmurs.[16] Three adult participants, 
yet no paediatric patients, were newly diagnosed with rheumatic heart disease. A 
recent study in South Africa has shown the decrease in rheumatic heart disease in 
children in South Africa, which may be due to improved access to health care and an 
improved socio-economic environment.[21] The use of echocardiography as a 
screening tool for rheumatic heart disease is yet to be translated into its impact on 
prognosis and effective secondary prophylaxis for subclinical disease. Results suggest 
that adults may benefit more from screening than children.[22]  
 
Of all indications for echocardiography, assessment of regional wall motion 
abnormalities and suspected hypertensive heart disease were statistically significantly 
associated with impact. The value of echocardiography in assisting with the prognosis 
in these two settings has previously been proven.[23,24] One study found that the 
evaluation of wall motion abnormalities is the most statistically significant, 
independent prognostic data provided by TTE.[23] Even though the screening of all 
hypertensive patients when LVH is diagnosed has been suggested, as this implies a 
worse diagnosis, others feel that it probably would not intensify the treatment of the 
hypertension itself.[25,26] 
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In our study, heart failure did not comprise the majority of indications, which was the 
case in a systematic review of patients referred for OAE from primary care.[26] The 
role of TTE in providing new information in this context is nonetheless unsurpassed, 
by detecting LV dysfunction and either establishing or confirming the cause of 
failure.[18] This is of particular value in our setting, where heart failure is usually 
diagnosed and monitored by clinical means only. Diastolic dysfunction was not 
captured. The distinction from systolic dysfunction can be valuable, as 
echocardiography is the best non-invasive tool to confirm this, especially in light of 
its difficult assessment by means of physical examination.[27] Despite two-thirds of the 
cohort having a smoking history, low numbers of COPD and its complications were 
reported. Screening for and assessing cardiac complications, such as cor pulmonale 
and pulmonary hypertension, in patients with COPD can be useful, as both infer 
increased morbidity and mortality.[28] The diagnosis of a clinically unsuspected atrial 
myxoma in this small cohort was noted as a finding that would otherwise have 
remained undetected. 
 
Discrepancies between the results of the TTEs and the assessment of the doctor prior 
to the test were confirmed as per previous studies.[18,29,30] It appears that the positive 
impact of TTE is independent of the clinical accuracy of the referring doctor. On the 
other hand, a lack of impact was nonetheless associated with accurate pre-referral 
assessment. This may indicate that a thorough history and physical examination may 
lessen the need for a diagnostic test.[19] Thirty-nine per cent of the echocardiograms 
disproved the pre-referral diagnosis and these consequences should be considered. 
 
In the present study, some of the participants had previous TTEs. A repeat 
echocardiogram still had an important clinical impact. A former study found the 
added diagnostic value of echocardiography to be significantly independent from 
whether this test was previously performed.[19]  
 
Approximately one-fifth of the patients were referred from the hospital’s emergency 
department; this may indicate the need for training in question-focused, point-of-care 
studies. A review of TTEs performed by non-cardiologists showed an active change 
in management in 16 to 37% of patients in an emergency setting.[9]  
 
A lack of referral of patients from primary health care facilities was found despite 
doctors being able to refer patients directly for TTEs. It is unclear whether the 
medical staff in these facilities are aware of this service. However, of the few patients 
in this study cohort who were referred from community health care settings, the 
echocardiograms were associated with notable impact. 
 
The waiting time for the next available appointment was six times as long as the 
recommended time period of two weeks advised by the National Institute for Care 
Excellence guidelines for patients with chronic heart failure and post myocardial 
infarction.[31] A Dutch study of OAE reports a waiting time of five weeks.[7] In 
developing countries, a lack of resources and scarce skills may be the reason for this 
long waiting time. The poor socio-economic status of the participants, including 
pensioners and those receiving disability grants, may indicate the reliance on public 
sector facilities. The poor attendance for TTE appointments shows the undervaluing 
of this restricted resource. Often, non-attendance is due to lack of funds for transport. 
Having this service only at a distant tertiary centre may add to poor attendance.  
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Limitations 
Our study does have some limitations. The participants were referred from the 
hospital ward or outpatient departments and have been pre-screened after being 
admitted via the emergency department or referred from a primary health care facility. 
This may overvalue the impact owing to a lower incidence of negative findings. 
Patients with acute cardiac illness, such as heart failure or myocardial infarction, may 
be more likely to benefit from echocardiograms. Any new information provided by 
echocardiography may be perceived as beneficial. No true comparator exists to match 
its value in imaging function and structure. 
 
Owing to the limited availability of TTEs in this setting as well as the inclusion of 
hospitalised patients, the likelihood of appropriate referrals by doctors will probably 
be higher.[11,32] Patients from the community have been found to have a lower pre-test 
probability and are mainly referred to exclude disease.[33] 
 
The echocardiographer in our study is an experienced cardiologist. His specialist 
assessment in itself may have an impact on patients’	management, causing the impact 
of the TTEs to be overestimated. The risk of possible bias exists, as this cardiologist 
performing the echocardiograms was also involved in the clinical decision-making 
process and management of the patients. We aimed to limit this bias by using pre-set 
questionnaires. The echocardiographic assessments were not comprehensive  
echocardiograms. This study did however not aim to address diagnostic accuracy.  
 
No particular guidelines were agreed upon in the study protocol. The questionnaire 
completed by the cardiologist during data collection indicated a binary option of 
whether a finding was present or not. Different measurements, e.g. valve area for 
stenotic lesions or pulmonary pressures in pulmonary hypertension, may have been 
done, but were not captured. 
 
The study size was smaller than initially anticipated, mainly because of patients 
defaulting on their appointments.  
 
Following the participants’	 completion of the questionnaires, all data were checked 
afterwards to correlate with the clinical information in their folders. This allowed for 
more accurate analysis of the patient characteristics and the echocardiograms as well 
as their indications. Fifteen patient folders were missing and were not checked 
retrospectively. 
 
The downstream risks of TTE, such as incorrect interpretation and residual anxiety 
despite a normal study, should not be disregarded.[1,14,34] 
 
It would be important to gain insight into whether clinical impact and changes in 
management eventually translate into improved health outcomes in primary care. 
These effects could be assessed in a follow-up study. Other than its clinical impact, 
the cost implications of a restricted resource should be studied. This should rather be 
done in a cost-analysis and not an impact study. In a stressed economic environment 
of cost-containment, the various accepted indications lend themselves to remunerative 
abuse.[1] Remuneration is of less concern in the public sector than access and ethical 
principles, such as distributive justice.  
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Conclusion 
Echocardiography has a positive impact on patient management in a district hospital 
setting. The limited access for patients may negatively impact their management, as a 
valuable contribution of TTEs to overall management was found. The burden of non-
communicable conditions is evident in the cohort referred for this service. 
 
A normal echocardiographic study is important by offering patient-centred 
reassurance, offering diagnostic value to the doctor and aiding in down-referral back 
to the primary level of care. In the overburdened public health sector, where 
continuity of care is frequently a problem, it may reduce time and costs. By providing 
these services in non-tertiary settings, patients can be screened and more 
appropriately referred to scarce upstream specialists and sub-specialist departments. 
 
Training in interpretation and accreditation in the use of echocardiography should be 
a priority for teaching and academic facilities, especially for those working in general, 
emergency and family medicine. The prospect of hand-held devices would definitely 
enhance access, but may compromise quality.  
 
On a practical level, the training in basic echocardiography may empower other health 
care providers, such as general practitioners with a special interests in cardiology, to 
provide care at district facilities whilst tertiary-based cardiologists may have an 
advisory role only. Many conditions can then be promptly managed in the non-tertiary 
setting, albeit the primary health care (as in OAE) or the district health system, 
without the assessment of a cardiologist. It may lead to more appropriate use of and 
referral to cardiologists. The benefits of more accurate diagnosis, improving rational 
prescription and decreasing the burden on the tertiary health care system should be 
evaluated. A patient-centred approach can also evaluate patients’	own perception of 
impact on their illness.  
 
Policy makers should be alerted to the added value offered by TTEs of an 
echocardiographic assessment and the risk of its restricted access, especially when 
comparing its essential practice in developed countries. The rapidly growing burden 
of non-communicable diseases urges investment in greater accountability and equity 
of service-based interventions to local communities.[4,33] Some services have shown 
promise by altering the concept of open access to “managed direct access”,[20] by 
prioritising referrals according to appropriateness and impact. District hospitals can 
establish protocols in the communities they serve to assist with procurement and 
referrals from primary health care.  
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